News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Jennerex Inks Deal with Lee's Pharmaceutical Holdings in China


11/18/2009 7:45:57 AM

Bookmark and Share

San Francisco Business Times -- Cancer medicine company Jennerex Inc. signed a deal with Lee’s Pharmaceutical Holdings Ltd. for development and sales of its lead drug. San Francisco-based Jennerex is now testing that drug, JX-594, against liver and colorectal cancers. This deal gives Hong Kong-based Lee’s rights to the drug to treat various cancers in China, Hong Kong and Macau.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES